Sanjeev Mehra Acquires 350,000 Shares of Avantor (NYSE:AVTR) Stock

Avantor, Inc. (NYSE:AVTRGet Free Report) Director Sanjeev Mehra acquired 350,000 shares of the business’s stock in a transaction on Friday, December 5th. The shares were purchased at an average price of $11.09 per share, for a total transaction of $3,881,500.00. Following the transaction, the director directly owned 350,000 shares of the company’s stock, valued at approximately $3,881,500. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link.

Avantor Price Performance

Avantor stock opened at $11.55 on Thursday. Avantor, Inc. has a 12-month low of $10.62 and a 12-month high of $23.32. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The firm has a 50-day moving average price of $12.56 and a 200-day moving average price of $12.87. The firm has a market capitalization of $7.87 billion, a PE ratio of -88.81, a price-to-earnings-growth ratio of 3.66 and a beta of 0.93.

Avantor (NYSE:AVTRGet Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The company reported $0.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.23 by ($0.01). Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The firm had revenue of $1.62 billion during the quarter, compared to the consensus estimate of $1.65 billion. During the same period in the previous year, the business earned $0.26 EPS. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. Avantor has set its FY 2025 guidance at 0.880-0.920 EPS. As a group, equities research analysts forecast that Avantor, Inc. will post 1.06 EPS for the current year.

Institutional Investors Weigh In On Avantor

Hedge funds have recently modified their holdings of the business. Dodge & Cox increased its holdings in Avantor by 0.3% during the third quarter. Dodge & Cox now owns 117,746,888 shares of the company’s stock valued at $1,469,481,000 after buying an additional 313,404 shares during the period. Vanguard Group Inc. boosted its position in Avantor by 1.8% during the 3rd quarter. Vanguard Group Inc. now owns 65,988,977 shares of the company’s stock valued at $823,542,000 after acquiring an additional 1,135,279 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in shares of Avantor by 1.5% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 41,969,199 shares of the company’s stock valued at $680,321,000 after acquiring an additional 608,806 shares during the period. Barrow Hanley Mewhinney & Strauss LLC raised its position in shares of Avantor by 10.8% in the 3rd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 34,548,129 shares of the company’s stock worth $431,161,000 after acquiring an additional 3,356,861 shares in the last quarter. Finally, Greenhaven Associates Inc. purchased a new stake in shares of Avantor during the 3rd quarter worth $228,528,000. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the topic of several research analyst reports. Evercore ISI cut their price objective on Avantor from $16.00 to $14.00 and set an “outperform” rating on the stock in a research report on Thursday, October 30th. Robert W. Baird boosted their target price on shares of Avantor from $15.00 to $17.00 and gave the company an “outperform” rating in a research note on Friday, October 24th. UBS Group set a $12.00 price target on shares of Avantor in a research note on Thursday, October 30th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $12.00 price objective (down previously from $14.00) on shares of Avantor in a report on Thursday, October 30th. Finally, Raymond James Financial downgraded shares of Avantor from an “outperform” rating to a “market perform” rating in a research note on Tuesday, November 4th. Four research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $14.42.

View Our Latest Analysis on AVTR

About Avantor

(Get Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Insider Buying and Selling by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.